Autoimmune markers in screening for orbital inflammatory disease.

Terence W AngValerie JuniatDinesh Selva

Published in: Eye (London, England) (2022)

Serological testing alone may not provide a clear direction for further investigation of orbital inflammation and a biopsy may occur independently of the serological results. The value of autoimmune markers may lie in subsequent follow-up as patients may develop suggestive symptoms after an indeterminate positive result or initially seronegative disease.

Keyphrases

oxidative stress
end stage renal disease
multiple sclerosis
ejection fraction
newly diagnosed
prognostic factors
fine needle aspiration
drug induced
patient reported outcomes
ultrasound guided